Abstract -
Objective
Aortic stenosis has traditionally been addressed with surgical aortic
valve replacement with a stented prosthesis. Several technologies have
emerged as an alternative treatment method for aortic valve disease.
Among them, Perceval Sutureless valve has been used in clinical practice
for more than a decade. The aim of this study was to evaluate the
results of Perceval Sutureless valve from single centre in Indian
population.
Method
Between April 2018 to December 2021, 30 elective patients underwent
aortic valve replacement with the Perceval Sutureless valve. 19 patients
had isolated AVR and 11 patients underwent AVR + Coronary artery bypass
grafting (CABG) with average grafts 2.1 ± 0.8. Majority of isolated AVR,
12 of 19, were done by minimally invasive approach.
Result
Mean age was 67.3 ± 13.8 and mean STS score was 2.7 ± 1.5. Mean aortic
cross clamp time for isolated AVR and combined procedure were 42 ± 11
and 74 ± 23 respectively. There was no in-hospital mortality. 3 patients
required ventilation for > 24 hours. New onset left bundle
branch block occurred in 4 patients which recovered before discharge in
2 patients. The peak and mean valve gradients were satisfactory. None of
implanted valve showed para-valvular leak.
Conclusion
SAVR using Perceval Sutureless valve is associated with excellent
results and represent a safe and effective treatment option for patients
with severe AS. This valve also facilitates MI approach and reduces
aortic x-clamp and cardiopulmonary bypass time.
Key Words: Aortic Stenosis, AVR, Minimally Invasive Surgery,
Sutureless Valve